Sequential observation of antibody response pattern at 3 and 6 months following ChAdOx1 nCoV-19 vaccination among health care workers-A prospective single cohort study

Sequential observation of antibody response pattern at 3 and 6 months following ChAdOx1 nCoV-19 vaccination among health care workers-A prospective single cohort study

Background: The duration of the immune response induced by ChAdOx1 nCoV-19 vaccination in a real-world setting is unknown. Objectives: This study is aimed to estimate the 6-month trend of SARS-CoV-2 antibody titer after Covishield vaccination among Health Care workers (HCW) and their associated fac...

Full description

Bibliographic Details
Main Authors:	Ponnu Jose, Ramesh Bhaskaran, Sreeraj Vijay, Priyanka Rajmohan, Aboobacker Mohammed Rafi, Unnikrishnan Uttumadathil Gopinathan, Joe Thomas, Susheela J Innah, Lucy Raphael, Chithra Valsan, Praveenlal Kuttichira
Format:	Article
Language:	English
Published:	Guilan University of Medical Sciences 2022-10-01
Series:	Caspian Journal of Health Research
Subjects:	antibody response chadox1 ncov-19 vaccine health care workers prospective cohort
Online Access:	http://cjhr.gums.ac.ir/article-1-270-en.html

Similar Items

An autopsy case of cerebral arterial thrombosis after vaccination with ChAdOx1 nCOV-19
by: Hyeji Yang, et al.
Published: (2022-08-01)

Serosurveillance among healthcare workers vaccinated with ChAdOx1 nCoV-19 Corona vaccine in a tertiary hospital of Kerala, India: prospective cohort studу
by: S. K. Njarekkattuvalappil, et al.
Published: (2021-10-01)

Effectiveness of the chAdOx1 nCoV-19 vaccine in preventing COVID-19 infection
by: Tarana Sarwat, et al.
Published: (2022-01-01)

AZD1222 (ChAdOx1 nCoV-19) Vaccine: Hurdles and Visions
by: Md. Altamash Ahmad, et al.
Published: (2023-03-01)

Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan
by: Jer-Hwa Chang, et al.
Published: (2022-02-01)

The immunogenicity of the ChAdOx1 nCoV-19 vaccination in participants with underlying comorbidity diseases: A prospective cohort study
by: Thachanun Porntharukchareon, et al.
Published: (2023-08-01)

A Review on Suggested Mechanisms in Thrombocytopenia and Thrombosis Following ChAdOx1 nCoV-19 Vaccination
by: Negar Mottaghi Dastgerdi, et al.
Published: (2021-11-01)

Remitting seronegative symmetrical synovitis with pitting oedema following administration of the ChAdOx1-S/nCoV-19 Coronavirus vaccine
by: Syed Aun Muhammad, et al.
Published: (2023-06-01)

Immunogenicity Differences of the ChAdOx1 nCoV-19 Vaccine According to Pre-Existing Adenovirus Immunity
by: Jinnam Kim, et al.
Published: (2023-04-01)

Covid Antibody Titers in Cancer Patients Following Vaccination with ChAdOx1 nCOV-19 Vaccine
by: Ashish Chavan, et al.

Fatal myositis, rhabdomyolysis and compartment syndrome after ChAdOx1 nCoV-19 vaccination
by: Szu-Ting Huang, et al.
Published: (2022-12-01)

An Immunobridging Study to Evaluate the Neutralizing Antibody Titer in Adults Immunized with Two Doses of Either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901
by: Josue Antonio Estrada, et al.
Published: (2022-04-01)

Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19
by: Jie Wei, et al.
Published: (2023-02-01)

Case report: Early onset Marin-Amat syndrome after receiving ChAdOx1 nCoV-19 vaccination
by: Ping-Feng Tsai, et al.
Published: (2022-11-01)

Immunogenicity evaluation of ChAdox1 nCov-19 (AZD1222) vaccine in solid cancer patients in Chulabhorn Hospital
by: Piyarat Limpawittayakul, et al.
Published: (2022-11-01)

Risk of Thrombosis Following the First Dose of ChAdOx1 nCoV-19 Vaccine in Patients Undergoing Maintenance Hemodialysis: A Self-Controlled Case Series Study
by: Shao SC, et al.
Published: (2023-09-01)

Acute Polyserositis with Cardiac Tamponade and Bilateral Refractory Pleural Effusion after ChAdOx1 nCoV-19 Vaccination
by: Guan-Yi Li, et al.
Published: (2022-08-01)

A Quantitative Benefit–Risk Analysis of ChAdOx1 nCoV-19 Vaccine among People under 60 in Italy
by: Raffaele Palladino, et al.
Published: (2021-06-01)

ChAdOx1 nCoV-19 Immunogenicity and Immunological Response Following COVID-19 Infection in Patients Receiving Maintenance Hemodialysis
by: Wisit Prasithsirikul, et al.
Published: (2022-06-01)

ChAdOx1 nCoV-19 Vaccine Side Effects among Healthcare Workers in Trinidad and Tobago
by: Chavin D. Gopaul, et al.
Published: (2022-03-01)

Severe but Self-Limiting Polyarthralgia with Functional Impairment Following ChAdOx1 nCov-19 Vaccination in an Elderly Recipient
by: Joel Ern Zher Chan, et al.
Published: (2021-10-01)

Adverse Events Following Immunization Associated with the First and Second Doses of the ChAdOx1 nCoV-19 Vaccine among Healthcare Workers in Korea
by: Minji Jeon, et al.
Published: (2021-09-01)

Safety of ChAdOx1 nCoV-19 Vaccine: Independent Evidence from Two EU States
by: Abanoub Riad, et al.
Published: (2021-06-01)

Comparison of Antibody Persistence up to 6 Months after Additional Booster Vaccination with ChAdOx1 nCoV-19 Vaccine
by: Pawita Suwanwattana, et al.
Published: (2023-06-01)

ChAdOx1 nCoV-19 Vaccine and Thrombosis with Thrombocytopenia Syndrome among Adults: A Systematic Review
by: Homa Faghihi, et al.
Published: (2023-11-01)

Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults
by: Prasad S. Kulkarni, et al.
Published: (2024-12-01)

The Effects of CoronaVac and ChAdOx1 nCoV-19 in Reducing Severe Illness in Thailand: A Retrospective Cohort Study
by: Thanyarat Promlek, et al.
Published: (2023-01-01)

High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic Events
by: Evangelos Terpos, et al.
Published: (2021-07-01)

Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study
by: Kriangkrai Tawinprai, et al.
Published: (2023-01-01)

Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies
by: Osman O. Radhwi, et al.
Published: (2022-01-01)

Platelet Activation and Cytokine Release of Interleukin-8 and Interferon-Gamma-Induced Protein 10 after ChAdOx1 nCoV-19 Coronavirus Vaccine Injection
by: Chih-Lung Shen, et al.
Published: (2023-02-01)

Robust specific RBD responses and neutralizing antibodies after ChAdOx1 nCoV-19 and CoronaVac vaccination in SARS-CoV-2– seropositive individuals
by: Edgar Ruz Fernandes, PhD, et al.
Published: (2023-05-01)

Effect of Inactivated SARS-CoV-2 Vaccines and ChAdOx1 nCoV-19 Vaccination to Prevent COVID-19 in Thai Households (VacPrevent trial)
by: Marisa Muadchimkaew, et al.
Published: (2022-11-01)

Temporal Association between Hampton’s Hump Pulmonary Embolism and First-Dose ChAdOx1 nCov-19 Vaccine in a Patient with Activated Protein C Resistance
by: Gernot Kriegshäuser, et al.
Published: (2022-10-01)

Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines
by: Guy Cohen, et al.
Published: (2022-11-01)

Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2
by: Ahmed Samir Abdelhafiz, et al.
Published: (2022-09-01)

Protective Immunity of COVID-19 Vaccination with ChAdOx1 nCoV-19 Following Previous SARS-CoV-2 Infection: A Humoral and Cellular Investigation
by: Tamiris Azamor, et al.
Published: (2022-08-01)

Vaccine-Related adverse events following AZD1222 (ChAdOx1-nCoV-19) Covid-19 vaccine in solid malignancy patients receiving cancer treatment, as compared to age-matched healthy controls
by: Nussara Pakvisal, et al.
Published: (2022-11-01)

Seven-Month Analysis of Five SARS-CoV-2 Antibody Assay Results after ChAdOx1 nCoV-19 Vaccination: Significant Decrease in SARS-CoV-2 Antibody Titer
by: Seri Jeong, et al.
Published: (2021-12-01)

Lung Transplant Recipients Immunogenicity after Heterologous ChAdOx1 nCoV-19—BNT162b2 mRNA Vaccination
by: Emilie Catry, et al.
Published: (2022-07-01)